Disclosure Of Effect Of Changes In Foreign Exchange Rates [Text Block]

Transgene - Filing #6250839

Concept	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	As at 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2024-01-01 to 2024-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	As at 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31	2023-01-01 to 2023-12-31
Disclosure of effect of changes in foreign exchange rates [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of information when currency is not exchangeable into another currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of information when foreign operation’s functional currency is not exchangeable into presentation currency [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [text block]	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—	—
Disclosure of summarised financial information about foreign operation [abstract]
Disclosure of summarised financial information about foreign operation [line items]
Non-current assets	—	—	—	—	21 506 EUR	—	—	—	—	—	—	27 233 EUR	—	—	—	—
Current assets	—	—	—	—	20 668 EUR	—	—	—	—	—	—	17 984 EUR	—	—	—	—
Non-current liabilities	—	—	—	—	12 986 EUR	—	—	—	—	—	—	19 563 EUR	—	—	—	—
Current liabilities	—	—	—	—	13 984 EUR	—	—	—	—	—	—	10 042 EUR	—	—	—	—
Profit (loss)	33 971 EUR	33 971 EUR	- EUR	- EUR	—	- EUR	- EUR	- EUR	- EUR	22 328 EUR	- EUR	—	22 328 EUR	- EUR	- EUR	- EUR
Other comprehensive income	196,000 EUR	—	—	—	—	—	—	—	—	192,000 EUR	—	—	—	—	—	—
Comprehensive income	33 775 EUR	33 971 EUR	- EUR	- EUR	—	- EUR	- EUR	196,000 EUR	- EUR	22 520 EUR	- EUR	—	22 328 EUR	- EUR	- EUR	192,000 EUR